Carsten Niemann

Carsten Niemann

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


  1. 2017
  2. Published

    TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy

    Eskelund, C. W., Dahl, C., Hansen, Jakob Werner, Westman, M., Kolstad, A., Pedersen, L. B., Montano-Almendras, C. P., Husby, Simon, Freiburghaus, C., Ek, S., Vestergaard, Anja Holm, Niemann, Carsten, Raty, R., Brown, Peter de Nully, Geisler, C. H., Andersen, M. K., Guldberg, P., Jerkeman, M. & Grønbæk, Kirsten, 2017, In: Blood. 130, 17, p. 1903-1910 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years

    Kolstad, A., Pedersen, L. B., Eskelund, C. W., Husby, S., Grønbæk, K., Jerkeman, M., Laurell, A., Räty, R., Elonen, E., Andersen, N. S., Brown, P. D. N., Kimby, E., Bentzen, H., Sundström, C., Ehinger, M., Karjalainen-Lindsberg, M. L., Delabie, J., Ralfkiær, E., Fagerli, U. M., Nilsson-Ehle, H. & 5 others, Lauritzsen, G. F., Kuittinen, O., Niemann, Carsten, Geisler, C. H. & the Nordic Lymphoma Group, T. N. L. G., Mar 2017, In: Biology of Blood and Marrow Transplantation. 23, 3, p. 428-435 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia

    Vojdeman, F. J., Herman, S. E. M., Kirkby, N., Wiestner, A., van T' Veer, M. B., Tjønnfjord, G. E., Itälä-Remes, M. A., Kimby, E., Farooqui, M. Z., Polliack, A., Wu, K. L., Doorduijn, J. K., Alemayehu, W. G., Wittebol, S., Kozak, T., Walewski, J., Abrahamse-Testroote, M. C. J., van Oers, M. H. J., Geisler, C. H. & Niemann, Carsten, 2017, In: Leukemia and Lymphoma. 58, 10, p. 2356-2362

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. 2018
  6. Published

    Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study

    Ahn, I. E., Farooqui, M. Z. H., Tian, X., Valdez, J., Sun, C., Soto, S., Lotter, J., Housel, S., Stetler-Stevenson, M., Yuan, C. M., Maric, I., Calvo, K. R., Nierman, P., Hughes, T. E., Saba, N. S., Marti, G. E., Pittaluga, S., Herman, S. E. M., Niemann, C. U., Pedersen, L. B. & 4 others, Geisler, C. H., Childs, R., Aue, G. & Wiestner, A., 2018, In: Blood. 131, 21, p. 2357-2366 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Immune failure, infection and survival in chronic lymphocytic leukemia in Denmark

    Andersen, M. A. & Niemann, Carsten, 1 Jul 2018, In: Haematologica. 103, 7, p. e330-e330

    Research output: Contribution to journalLetterResearchpeer-review

  8. Published

    Incidence and predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study

    Andersen, M. A., Eriksen, C. T., Brieghel, C., Biccler, J. L., Cunha-bang, C. D., Helleberg, M. & Niemann, Carsten, 2018, In: Haematologica. 103, 7, p. e300-e303

    Research output: Contribution to journalLetterResearchpeer-review

  9. Published

    No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy

    Baliakas, P., Mattsson, M., Hadzidimitriou, A., Minga, E., Agathangelidis, A., Sutton, L., Scarfo, L., Davis, Z., Yan, X., Plevova, K., Sandberg, Y., Vojdeman, F. J., Tzenou, T., Chu, C. C., Veronese, S., Mansouri, L., Smedby, K. E., Giudicelli, V., Nguyen-khac, F., Panagiotidis, P. & 20 others, Juliusson, G., Anagnostopoulos, A., Lefranc, M., Trentin, L., Catherwood, M., Montillo, M., Niemann, Carsten, Langerak, A. W., Pospisilova, S., Stavroyianni, N., Chiorazzi, N., Oscier, D., Jelinek, D. F., Shanafelt, T., Darzentas, N., Belessi, C., Davi, F., Ghia, P., Rosenquist, R. & Stamatopoulos, K., 1 Apr 2018, In: Haematologica. 103, 4, p. e158-e161

    Research output: Contribution to journalLetterResearchpeer-review

  10. Published

    Cocreated Smartphone App to Improve the Quality of Life of Adolescents and Young Adults with Cancer (Kræftværket): Protocol for a Quantitative and Qualitative Evaluation

    Elsbernd, A., Hjerming, M., Visler, C., Hjalgrim, L. L., Niemann, Carsten, Boisen, K. & Pappot, H., 2018, In: J M I R Research Protocols. 7, 5, 10 p., e10098.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Using Cocreation in the Process of Designing a Smartphone App for Adolescents and Young Adults With Cancer: Prototype Development Study

    Elsbernd, A., Hjerming, M., Visler, C., Hjalgrim, L. L., Niemann, Carsten, Boisen, K. A., Jakobsen, J. & Pappot, H., 2018, In: JMIR Formative Research. 2, 2, 9 p., e23.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial

    Jerkeman, M., Eskelund, C. W., Hutchings, M., Räty, R., Wader, K. F., Laurell, A., Toldbod, H., Pedersen, L. B., Niemann, Carsten, Dahl, C., Kuitunen, H., Geisler, C. H., Grønbæk, Kirsten & Kolstad, A., 2018, In: The Lancet Haematology. 5, 3, p. e109-e116 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia - Update on methodological approaches and results interpretation

    Malcikova, J., Tausch, E., Rossi, D., Sutton, L. A., Soussi, T., Zenz, T., Kater, A. P., Niemann, Carsten, Gonzalez, D., Davi, F., Gonzalez Diaz, M., Moreno, C., Gaidano, G., Stamatopoulos, K., Rosenquist, R., Stilgenbauer, S., Ghia, P. & Pospisilova, S., 1 May 2018, In: Leukemia. 32, 5, p. 1070-1080

    Research output: Contribution to journalReviewResearchpeer-review

  14. Published

    Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project

    Rawstron, A. C., Kreuzer, K., Soosapilla, A., Spacek, M., Stehlikova, O., Gambell, P., Mciver-brown, N., Villamor, N., Psarra, K., Arroz, M., Milani, R., De La Serna, J., Cedena, M. T., Jaksic, O., Nomdedeu, J., Moreno, C., Rigolin, G. M., Cuneo, A., Johansen, P., Johnsen, H. E. & 13 others, Rosenquist, R., Niemann, Carsten, Kern, W., Westerman, D., Trneny, M., Mulligan, S., Doubek, M., Pospisilova, S., Hillmen, P., Oscier, D., Hallek, M., Ghia, P. & Montserrat, E., 2018, In: Cytometry. Part B: Clinical Cytometry. 94, 1, p. 121-128 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Targeting Bruton's Tyrosine Kinase Across B-Cell Malignancies

    da Cunha-Bang, C. & Niemann, Carsten, 2018, In: Drugs. 78, 16, p. 1653-1663

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. 2019
  17. Published

    Epidemiology of bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal nation-wide cohort study

    Andersen, M. A., Moser, Claus Ernst, Lundgren, Jens & Niemann, Carsten, Mar 2019, In: Leukemia. 33, 3, p. 662-670 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Deep targeted sequencing of TP53 in chronic lymphocytic leukemia: clinical impact at diagnosis and at time of treatment

    Brieghel, C., Kinalis, S., Yde, C. W., Schmidt, A. Y., Jønson, L., Andersen, M. A., da Cunha-Bang, C., Pedersen, L. B., Geisler, C. H., Nielsen, Finn Cilius & Niemann, Carsten, Apr 2019, In: Haematologica. 104, 4, p. 789-796 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment

    De Weerdt, I., Hofland, T., De Boer, R., Dobber, J. A., Dubois, J., Van Nieuwenhuize, D., Mobasher, M., De Boer, F., Hoogendoorn, M., Velders, G. A., Van Der Klift, M., Remmerswaal, E. B. M., Bemelman, F. J., Niemann, Carsten, Kersting, S., Levin, M. D., Eldering, E., Tonino, S. H. & Kater, A. P., Sep 2019, In: Blood advances. 3, 17, p. 2642-2652

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Developing age-appropriate supportive facilities, resources, and activities for adolescents and young adults with cancer across departments and diagnoses: A single-center experience

    Elsbernd, A., Boisen, K. A., Hjerming, M., Niemann, Carsten, Petersen, G., Pappot, Helle & Hjalgrim, L. L., 2019, In: Journal of Adolescent and Young Adult Oncology. 8, 1, p. 98-102 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    Venetoclax and obinutuzumab in patients with CLL and coexisting conditions

    Fischer, K., Al-Sawaf, O., Bahlo, J., Fink, A. M., Tandon, M., Dixon, M., Robrecht, S., Warburton, S., Humphrey, K., Samoylova, O., Liberati, A. M., Pinilla-Ibarz, J., Opat, S., Sivcheva, L., Le Dû, K., Fogliatto, L. M., Niemann, C. U., Weinkove, R., Robinson, S., Kipps, T. J. & 12 others, Boettcher, S., Tausch, E., Humerickhouse, R., Eichhorst, B., Wendtner, C. M., Langerak, A. W., Kreuzer, K. A., Ritgen, M., Goede, V., Stilgenbauer, S., Mobasher, M. & Hallek, M., 2019, In: New England Journal of Medicine. 380, 23, p. 2225-2236 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: Protocol for a retrospective population-based cohort study

    Hleuhel, M. H., Ben-Dali, Y., Da Cunha-Bang, C., Brieghel, C., Clasen-Linde, E., Niemann, Carsten & Andersen, M. A., 2019, In: BMJ Open. 9, 3, 5 p., e023566.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Ibrutinib and venetoclax for first-line treatment of CLL

    Kater, A. P., Levin, M. D. & Niemann, Carsten, 2019, In: New England Journal of Medicine. 381, 8, p. 788-789 2 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  24. 2020
  25. Published

    Real-world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib

    Aarup, K., Rotbain, E. C., Enggaard, L., Pedersen, R. S., Bergmann, O. J., Thomsen, R. H., Frederiksen, M., Frederiksen, H., Nielsen, T., Christiansen, I., Andersen, M. A. & Niemann, Carsten, 2020, In: European Journal of Haematology. 105, 5, p. 646-654 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published

    Machine learning can identify newly diagnosed patients with CLL at high risk of infection

    Agius, R., Brieghel, C., Andersen, M. A., Pearson, A. T., Ledergerber, B., Cozzi-Lepri, A., Louzoun, Y., Andersen, Christen Bertel L, Bergstedt, J., von Stemann, J. H., Jørgensen, M., Tang, M. E., Fontes, M., Bahlo, J., Herling, C. D., Hallek, M., Lundgren, Jens, MacPherson, C. R., Larsen, J. & Niemann, Carsten, 2020, In: Nature Communications. 11, 1, 16 p., 363.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published

    Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial

    Al-Sawaf, O., Zhang, C., Tandon, M., Sinha, A., Fink, A. M., Robrecht, S., Samoylova, O., Liberati, A. M., Pinilla-Ibarz, J., Opat, S., Sivcheva, L., Le Dû, K., Fogliatto, L. M., Niemann, C. U., Weinkove, R., Robinson, S., Kipps, T. J., Tausch, E., Schary, W., Ritgen, M. & 6 others, Wendtner, C. M., Kreuzer, K. A., Eichhorst, B., Stilgenbauer, S., Hallek, M. & Fischer, K., 2020, In: The Lancet Oncology. 21, 9, p. 1188-1200 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  28. Published

    Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia: A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma

    Andersen, M. A., Valentin, R., Sjö, Lene Dissing, Borgwardt, L., Schmiegelow, Kjeld, Andersen, M. K., Marvig, R. L., Yde, C. W. & Niemann, Carsten, 2020, In: Acta Oncologica. 59, 12, p. 1547-1551

    Research output: Contribution to journalComment/debateResearchpeer-review

  29. Published

    Richter’s transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study

    Ben-Dali, Y., Hleuhel, M. H., da Cunha-Bang, C., Brieghel, C., Poulsen, C. B., Clasen-Linde, E., Bentzen, H. H. N., Frederiksen, H., Christiansen, I., Nielsen, L. H., Enggaard, L., Helleberg, M., Clausen, M., Frederiksen, M., Pedersen, R. S., Niemann, Carsten & Andersen, M. A., 2020, In: Leukemia and Lymphoma. 61, 6, p. 1435-1444 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 Next

ID: 185059285